PHARMA QUALITY GROUP: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA QUALITY GROUP
Largest movements
- Receivables within one year -€77,248
down €77,248 (-51.0%), from €151,532 to €74,284
of which Trade receivables: -€41,747
- Cash +€49,360
up €49,360 (+38.2%), from €129,216 to €178,576
mainly Net result for the year (+€98,068) and Receivables within one year (+€77,248)
- Intangible fixed assets -€3,496
down €3,496 (-35.0%), from €9,988 to €6,492
- Trade debts -€33,687
down €33,687 (-96.2%), from €35,036 to €1,348
- Tax, wage and social debts -€16,218
down €16,218 (-50.0%), from €32,430 to €16,212
of which Taxes: -€17,468
- Other debts +€16,133
up €16,133 (+24.0%), from €67,235 to €83,368
- Turnover -€321,029
no longer reported in 2025 (was €321,029)
- Purchases and services -€249,215
no longer reported in 2025 (was €249,215)
- Gross operating margin -€95,003
down €95,003, from €80,228 to -€14,775
- Financial income +€94,420
up €94,420 (+380%), from €24,817 to €119,237
- Taxes -€20,243
no longer reported in 2025 (was €20,243)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €312,029 | €277,888 | -€34,141 | -10.9% |
| Fixed assets | 21/28 | €31,270 | €24,933 | -€6,337 | -20.3% |
| Intangible fixed assets | 21 | €9,988 | €6,492 | -€3,496 | -35.0% |
| Tangible fixed assets | 22/27 | €17,282 | €14,881 | -€2,401 | -13.9% |
| Furniture and vehicles | 24 | €701 | - | -€701 | |
| Other tangible fixed assets | 26 | €16,581 | €14,881 | -€1,700 | -10.3% |
| Financial fixed assets | 28 | €4,000 | €3,560 | -€440 | -11.0% |
| Current assets | 29/58 | €280,759 | €252,955 | -€27,804 | -9.9% |
| Amounts receivable within one year | 40/41 | €151,532 | €74,284 | -€77,248 | -51.0% |
| Trade receivables | 40 | €41,829 | €82 | -€41,747 | -99.8% |
| Other amounts receivable | 41 | €109,703 | €74,202 | -€35,501 | -32.4% |
| Cash at bank and in hand | 54/58 | €129,216 | €178,576 | +€49,360 | +38.2% |
| Deferred charges and accrued income | 490/1 | €11 | €95 | +€84 | +778% |
| Total equity and liabilities | 10/49 | €312,029 | €277,888 | -€34,141 | -10.9% |
| Equity | 10/15 | €176,971 | €176,960 | -€11 | 0.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €158,360 | €158,360 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €156,500 | €156,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €11 | - | -€11 | |
| Amounts payable | 17/49 | €135,058 | €100,928 | -€34,130 | -25.3% |
| Amounts payable within one year | 42/48 | €135,058 | €100,928 | -€34,130 | -25.3% |
| Financial debts | 43 | €357 | - | -€357 | |
| Credit institutions | 430/8 | €357 | - | -€357 | |
| Trade debts | 44 | €35,036 | €1,348 | -€33,687 | -96.2% |
| Suppliers | 440/4 | €35,036 | €1,348 | -€33,687 | -96.2% |
| Taxes, remuneration and social security | 45 | €32,430 | €16,212 | -€16,218 | -50.0% |
| Taxes | 450/3 | €32,430 | €14,962 | -€17,468 | -53.9% |
| Remuneration and social security | 454/9 | - | €1,250 | +€1,250 | |
| Other amounts payable | 47/48 | €67,235 | €83,368 | +€16,133 | +24.0% |
| Turnover | 70 | €321,029 | - | -€321,029 | |
| Non-recurring operating income | 76A | €3,500 | - | -€3,500 | |
| Goods, raw materials, services and sundry goods | 60/61 | €249,215 | - | -€249,215 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,255 | €5,897 | +€642 | +12.2% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Non-recurring operating charges | 66A | €10 | €0 | -€10 | -99.9% |
| Gross operating margin | 9900 | €80,228 | -€14,775 | -€95,003 | |
| Operating profit (loss) | 9901 | €74,575 | -€21,072 | -€95,647 | |
| Financial income | 75/76B | €24,817 | €119,237 | +€94,420 | +380% |
| Recurring financial income | 75 | €24,817 | €119,237 | +€94,420 | +380% |
| Financial charges | 65/66B | €118 | €97 | -€22 | -18.3% |
| Recurring financial charges | 65 | €118 | €97 | -€22 | -18.3% |
| Profit (loss) for the period before taxes | 9903 | €99,274 | €98,068 | -€1,205 | -1.2% |
| Income taxes | 67/77 | €20,243 | - | -€20,243 | |
| Profit (loss) for the period | 9904 | €79,031 | €98,068 | +€19,038 | +24.1% |
| Profit (loss) for the period to be appropriated | 9905 | €79,031 | €98,068 | +€19,038 | +24.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.